OBJECTIVE: To evaluate access to treatment after community-based HPV testing as testing within screen-and-treat programs has the potential to lower mortality from cervical cancer in low-resource settings. METHODS: A prospective cohort study was conducted in western Kenya in 2018. Women aged 25-65 years underwent HPV self-testing. HPV-positive women were referred for cryotherapy. Participant data were obtained from questionnaires during screening and treatment. The proportion successfully accessing treatment and variables associated with successful treatment was determined. RESULTS: Of the 750 women included, 140 (18.6%) tested positive for HPV. Of them, 135 were notified of their results, of whom 77 (59.2%) sought treatment and 73 (52.1%) received cryotherapy. Women who received treatment had a shorter time from screening to result notification (median 92 days, interquartile range [IQR] 84-104) compared to those who did not (97 days, IQR 89-106; P=0.061). In adjusted analyses, women with a history of cervical cancer screening (odds ratio [OR] 11, 95% confidence interval [CI] 1.42-85.20) and those electing result notification through a home visit (OR 4, 95% CI 1.23-14.17) were significantly more likely to acquire treatment at follow-up. CONCLUSION: Linkage to treatment after community-based HPV screening in this population was low, highlighting the need for strategies aimed at strengthening treatment linkage in similar settings.
OBJECTIVE: To evaluate access to treatment after community-based HPV testing as testing within screen-and-treat programs has the potential to lower mortality from cervical cancer in low-resource settings. METHODS: A prospective cohort study was conducted in western Kenya in 2018. Women aged 25-65 years underwent HPV self-testing. HPV-positive women were referred for cryotherapy. Participant data were obtained from questionnaires during screening and treatment. The proportion successfully accessing treatment and variables associated with successful treatment was determined. RESULTS: Of the 750 women included, 140 (18.6%) tested positive for HPV. Of them, 135 were notified of their results, of whom 77 (59.2%) sought treatment and 73 (52.1%) received cryotherapy. Women who received treatment had a shorter time from screening to result notification (median 92 days, interquartile range [IQR] 84-104) compared to those who did not (97 days, IQR 89-106; P=0.061). In adjusted analyses, women with a history of cervical cancer screening (odds ratio [OR] 11, 95% confidence interval [CI] 1.42-85.20) and those electing result notification through a home visit (OR 4, 95% CI 1.23-14.17) were significantly more likely to acquire treatment at follow-up. CONCLUSION: Linkage to treatment after community-based HPV screening in this population was low, highlighting the need for strategies aimed at strengthening treatment linkage in similar settings.
Authors: Megan J Huchko; Saduma Ibrahim; Cinthia Blat; Craig R Cohen; Jennifer S Smith; Robert A Hiatt; Elizabeth Bukusi Journal: Int J Gynaecol Obstet Date: 2018-01-03 Impact factor: 3.561
Authors: Hong-Ha M Truong; Eliud Akama; Mary A Guzé; Frankline Otieno; Duncan Obunge; Esther Wandera; Ntwali Placide Nsengiyumva; Sammy Obabo; Dena Bushman; Kevin Kadede; Elizabeth A Bukusi; Patrick Oyaro; Craig R Cohen Journal: J Acquir Immune Defic Syndr Date: 2019-12-01 Impact factor: 3.731
Authors: Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2018-09-12 Impact factor: 508.702
Authors: Margot Kunckler; Fanny Schumacher; Bruno Kenfack; Rosa Catarino; Manuela Viviano; Eveline Tincho; Pierre-Marie Tebeu; Liliane Temogne; Pierre Vassilakos; Patrick Petignat Journal: Cancer Med Date: 2017-06-04 Impact factor: 4.452
Authors: Anne Ng'ang'a; Mary Nyangasi; Nancy G Nkonge; Eunice Gathitu; Joseph Kibachio; Peter Gichangi; Richard G Wamai; Catherine Kyobutungi Journal: BMC Public Health Date: 2018-11-07 Impact factor: 3.295
Authors: Lori Brand Bateman; Shaundra Blakemore; Alaya Koneru; Thereza Mtesigwa; Renicha McCree; Nedra F Lisovicz; Eric A Aris; Safina Yuma; Julius D Mwaiselage; Pauline E Jolly Journal: Oncologist Date: 2018-06-22
Authors: Yujung Choi; Saduma Ibrahim; Lawrence P Park; Craig R Cohen; Elizabeth A Bukusi; Megan J Huchko Journal: BMC Womens Health Date: 2022-04-18 Impact factor: 2.742